Adams Diversified Equity Fund, Inc. Akebia Therapeutics, Inc. Transaction History

Adams Diversified Equity Fund, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 26, 2018	SELL	$9.15 - $11.34 $260,775 - $323,190	-28,500 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$14.24 - $19.59 $267,712 - $368,292	-18,800 Reduced 39.75%	28,500 $424,000
Q3 2017 Oct 30, 2017	BUY	$13.06 - $19.67 $617,738 - $930,391	47,300	47,300 $930,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.